公司资料
Kodiak Sciences 股价、新闻与催化剂
- 股票代码:
- KOD
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
37.22 USD (-2.90%)
收盘价
最后更新: 2026年8月24日
2.08B USD
市值
股价为何变动
As of Aug 24, 2026, KOD closed down 2.90% at $37.22. No new same-company headline was identified in the current news window.
公司概览
业务概览
Kodiak Sciences is a retinal-disease company focused on ophthalmology and long-duration eye therapies. Its story has been shaped by the challenge of building a differentiated retina franchise.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Kodiak sits in specialty ophthalmology biotechnology.
商业模式特征
The company depends on clinical data, delivery strategy, and the ability to create a durable retinal-disease platform.
生物医药行业定位
Kodiak is a high-beta eye-care name with strong sensitivity to data and execution risk.
未来催化剂
- Kodiak is now mostly a legacy and transaction-closeout name, so the catalysts are any final ophthalmology or strategic milestones that clarify remaining value. The market is not treating it like a fresh growth story anymore.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。